Aoi Hayasaki

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017

Shuji Isaji, Shugo Mizuno, John A. Windsor et al. · Pancreatology · 2017 · 751 citations · Full text

Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer

Aoi Hayasaki, Shuji Isaji, Masashi Kishiwada et al. · Cancers · 2018 · 50 citations · Full text

Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma: CEA Level Before Operation is a Significant Prognostic Indicator in Patients With Locally Advanced Pancreatic Cancer Treated With Neoadjuvant Therapy Followed by Surgical Resection

Hiroyuki Kato, Masashi Kishiwada, Aoi Hayasaki et al. · Annals of Surgery · 2020 · 45 citations · Full text

Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status

Naohisa Kuriyama, Masanobu Usui, Kazuaki Gyoten et al. · BMC Cancer · 2020 · 35 citations · Full text

Prognostic Nutritional Index after Chemoradiotherapy Was the Strongest Prognostic Predictor among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients

Ken Ichikawa, Shugo Mizuno, Aoi Hayasaki et al. · Cancers · 2019 · 29 citations · Full text